| Issue Date | Title | Author(s) |
| Apr-2020 | Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors | Wang, Zhijie; Duan, Jianchun; Wang, Guoqiang; Zhao, Jing; Xu, Jiachen; Han, Jiefei; Zhao, Zhengyi; Zhao, Jun; Zhu, Bo; Zhuo, Minglei; Sun, Jianguo; Bai, Hua; Wan, Rui; Wang, Xin; Fei, Kailun; Wang, Shuhang; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Huang, Depei; Qi, Chuang; Gao, Chan; Bai, Yuezong; Dong, Hua; Xiong, Lei; Tian, Yanhua; Wang, Di; Xu, Chunwei; Wang, Wenxian; Li, Junling; Hu, Xingsheng; Cai, Shangli; Wang, Jie |
| 2019 | Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel | Wang, Zhijie; Duan, Jianchun; Cai, Shangli; Han, Miao; Dong, Hua; Zhao, Jun; Zhu, Bo; Wang, Shuhang; Zhuo, Minglei; Sun, Jianguo; Wang, Qiming; Bai, Hua; Han, Jiefei; Tian, Yanhua; Lu, Jing; Xu, Tongfu; Zhao, Xiaochen; Wang, Guoqiang; Cao, Xinkai; Li, Fugen; Wang, Dalei; Chen, Yuejun; Bai, Yuezong; Zhao, Jing; Zhao, Zhengyi; Zhang, Yuzi; Xiong, Lei; He, Jie; Gao, Shugeng; Wang, Jie |
| 2019 | Comprehensive immune transcriptomic subtypes of colorectal cancer for development of precision immunotherapy. | Jing, Zhou; Guo, Xueguang; Zhao, Jing; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Cai, Shangli; Zhu, Haitao |
| 30-Jan-2023 | Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer | Gao, Zhaoya; Huang, Dandan; Chen, Hui; Yang, Yong; An, Ke; Ding, Changmin; Yuan, Zheping; Zhai, Zhichao; Niu, Pengfei; Gao, Qingkun; Cai, Jinping; Zeng, Qingmin; Wang, Yanzhao; Hong, Yuming; Rong, Wanshui; Huang, Wensheng; Lei, Fuming; Wang, Xiaodong; Chen, Shiqing; Zhao, Xiaochen; Bai, Yuezong; Gu, Jin |
| 20-May-2021 | Genomic characteristics of endometrial cancer in China. | Zheng, Hong; Cui, Lina; Zhang, Bei; Zhao, Xiaochen |
| 20-May-2020 | Genomic profiling and mutation burden of Chinese prostate patients with microsatellite instability. | Zhang, Ning; Hong, Baoan; Zhao, Xiaochen; Bai, Yuezong |
| Sep-2023 | Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial | Zhang, Wenwen; Tong, Shuang; Hu, Bingyang; Wan, Tao; Tang, Haowen; Zhao, Feilong; Jiao, Tianyu; Li, Junfeng; Zhang, Ze; Cai, Jinping; Ye, Huiyi; Wang, Zhanbo; Chen, Shiqing; Wang, Yafei; Li, Xuerui; Wang, Fangzhou; Cao, Junning; Tian, Lantian; Zhao, Xiaochen; Chen, Mingyi; Wang, Hongguang; Cai, Shouwang; Hu, Minggen; Bai, Yuezong; Lu, Shichun |
| Sep-2021 | Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy | Zhang, Meng; Qi, Changsong; Wang, Zhenghang; Chen, Hui; Zhao, Xiaochen; Zhang, Xueming; Zhou, Yifan; Gao, Chan; Bai, Yuezong; Jia, Shuqin; Ji, Jiafu |
| Aug-2020 | A novel loci-selected method for microsatellite instability detection validated on a large Chinese cohort | Li, Jian; Wang, Zhenghang; Yang, Bo; Li, Bin; Song, Yunjie; Zhang, Bei; Zhao, Xiaochen; Zhou, Yifan; Xie, Zhenghua; Li, Xiaofang; Chen, Hao; Dong, Hua; Bai, Yuezong; Xiong, Lei; Li, Fugen; Gao, Jing; Shen, Lin |
| 2023 | PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study | Chen, Mifen; Wang, Zhenghang; Liu, Zimin; Deng, Ting; Wang, Xiaodong; Chang, Zhiwei; Zhang, Qi; Yang, Wenlei; Liu, Ning; Ji, Zhi; Zhang, Xiaotian; Wang, Xicheng; Peng, Zhi; Li, Yi; Cao, Yujuan; Jin, Xuan; Lu, Hongxia; Qu, Huajun; Tang, Yong; Xu, Chunlei; Fang, Weijia; Zhang, Hangyu; Yan, Dong; Wang, Li; Li, Jiayi; Zhang, Jingdong; Wang, Qiwei; Xue, Liying; Yin, Fei; Han, Guangjie; Cheng, Zhiqiang; Liu, Qing; Jin, Yongdong; Zhang, Yinjie; Li, Lanxing; Cao, Baoshan; Yao, Yanhong; Chen, Zhiyu; Zou, Jianling; Ying, Jieer; Wei, Qing; Tian, Tiantian; Zhao, Weifeng; Li, Longmei; Zhang, Tong; Song, Fanghua; Ba, Ya-er; Li, Na; Gao, Hui; Ji, Yinghua; Bao, Liying; Zhao, Xiaochen; Cai, Jinping; Yuan, Zheping; Shen, Lin; Li, Jian |
| 2023 | PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study | Chen, Mifen; Wang, Zhenghang; Liu, Zimin; Deng, Ting; Wang, Xiaodong; Chang, Zhiwei; Zhang, Qi; Yang, Wenlei; Liu, Ning; Ji, Zhi; Zhang, Xiaotian; Wang, Xicheng; Peng, Zhi; Li, Yi; Cao, Yujuan; Jin, Xuan; Lu, Hongxia; Qu, Huajun; Tang, Yong; Xu, Chunlei; Fang, Weijia; Zhang, Hangyu; Yan, Dong; Wang, Li; Li, Jiayi; Zhang, Jingdong; Wang, Qiwei; Xue, Liying; Yin, Fei; Han, Guangjie; Cheng, Zhiqiang; Liu, Qing; Jin, Yongdong; Zhang, Yinjie; Li, Lanxing; Cao, Baoshan; Yao, Yanhong; Chen, Zhiyu; Zou, Jianling; Ying, Jieer; Wei, Qing; Tian, Tiantian; Zhao, Weifeng; Li, Longmei; Zhang, Tong; Song, Fanghua; Ba, Ya-er; Li, Na; Gao, Hui; Ji, Yinghua; Bao, Liying; Zhao, Xiaochen; Cai, Jinping; Yuan, Zheping; Shen, Lin; Li, Jian |
| 2020 | Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment | Wang, Zhenghang; Zhao, Xiaochen; Gao, Chan; Gong, Jifang; Wang, Xicheng; Gao, Jing; Li, Zhongwu; Wang, Jie; Yang, Bo; Wang, Lei; Zhang, Bei; Zhou, Yifan; Wang, Dalei; Li, Xiaofang; Bai, Yuezong; Li, Jian; Shen, Lin |
| 2021 | Prevalence and spectrum of germline cancer susceptibility gene variants and somatic second hits in colorectal cancer | Liao, Haiyan; Cai, Songhua; Bai, Yuezong; Zhang, Bei; Sheng, Yuling; Tong, Shuang; Cai, Jinping; Zhao, Feilong; Zhao, Xiaochen; Chen, Shiqing; Zhang, Cheng; Gao, Jing |
| 1-Jun-2022 | Recurrence risk stratification model for patients with stage I-III colorectal cancer based on clinicopathological and postoperative ctDNA predictors. | Gu, Jin; Lei, Fuming; Wang, Xiaodong; Chen, Hui; Huang, Wensheng; He, Xiaomang; Hong, Yuming; Zeng, Qingmin; Wang, Yanzhao; Gao, Qingkun; Yuan, Zheping; Niu, Pengfei; Huang, Dandan; Gao, Zhaoya; Ding, Changming; Zhai, Zhichao; An, Ke; Chen, Shiqing; Zhao, Xiaochen; Bai, Yuezong |
| Mar-2020 | Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer A Systematic Review and Meta-analysis | Duan, Jianchun; Cui, Longgang; Zhao, Xiaochen; Bai, Hua; Cai, Shangli; Wang, Guoqiang; Zhao, Zhengyi; Zhao, Jing; Chen, Shiqing; Song, Jia; Qi, Chuang; Wang, Qing; Huang, Mengli; Zhang, Yuzi; Huang, Depei; Bai, Yuezong; Sun, Feng; Lee, J. Jack; Wang, Zhijie; Wang, Jie |
